5LXC image
Deposition Date 2016-09-20
Release Date 2016-10-26
Last Version Date 2024-11-20
Entry Detail
PDB ID:
5LXC
Keywords:
TRANSFERASE
Title:
Crystal structure of DYRK2 in complex with EHT 5372 (Compound 1)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.15 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
C 1 2 1
5LXC validation report
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Dual specificity tyrosine-phosphorylation-regulated kinase 2
Gene (Uniprot):DYRK2
Chain IDs:A, B
Chain Length:408
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:Q92630 Pfam ID:PF00069 EC:2.7.12.1
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR A TYR modified residue
Ligand Molecules
7AA
EDO
Primary Citation
An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases.
J. Med. Chem. 59 10315 10321 (2016)
PMID: 27766861 DOI: 10.1021/acs.jmedchem.6b01083

Abstact

Methyl 9-anilinothiazolo[5,4-f]quinazoline-2-carbimidates 1 (EHT 5372) and 2 (EHT 1610) are strong inhibitors of DYRK's family kinases. The crystal structures of the complex revealed a noncanonical binding mode of compounds 1 and 2 in DYRK2, explaining the remarkable selectivity and potency of these inhibitors. The structural data and comparison presented here provide therefore a template for further improvement of this inhibitor class and for the development of novel inhibitors selectively targeting DYRK kinases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
5LXC